Top Markets
#1 Nesa Nesa +719.77%
#2 EXOD EXOD +22.78%
#3 Pons Pons +11.59%
#4 MetaDAO MetaDAO +11.24%
#5 Venom Venom +10.94%
#6 Ontology Gas Ontology Gas +9.15%
#7 Status Status +9.08%
#8 PondCoin PondCoin +8.53%
#9 Prom Prom +8.47%
#10 Wrapped NXM Wrapped NXM +7.71%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Connect Biopharma Holdings Limited Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTB
Rank in Stocks #19727
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical... Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
Share Price
$2.42
Last synced: 2026-08-25
Market Cap
$152.37M
Change (1 day)
5.22%
Change (1 year)
39.88%
Country
US
Trade Connect Biopharma Holdings Limited (CNTB)

Category

Healthcare
Stock price history for Connect Biopharma Holdings Limited (CNTB)
Highest end of day price: $2.35 on 2026-08-01

Lowest end of day price: $17.02 on 2021-03-01
Stock price history of Connect Biopharma Holdings Limited from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -8.60%
2025 129.78%
2024 18.63%
2023 21.12%
2022 -83.36%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.02 -11.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH